CASE REPORT: PDF OnlyDiode Laser Transscleral Cyclophotocoagulation in the Treatment of Refractory Glaucoma with Iris MelanocytomaChen, Mei-Jua; Liu, Jui-Linga, *; Li, Wing-Yinb, d; Lee, Fenq-Liha; Chou, Ching-Kuanga; Hsu, Wen-MingaAuthor Information aDepartment of Ophthalmology, Taipei, Taiwan, R.O.C. bDepartment of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C. dDepartment of Pathology, National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C. *Correspondence to: Dr Jui-Ling Liu, Department of Ophthalmology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C. E-mail: [email protected] Received: August 30, 2007; • Accepted: May 8, 2008. Journal of the Chinese Medical Association: October 2008 - Volume 71 - Issue 10 - p 546-548 doi: 10.1016/S1726-4901(08)70166-7 Metrics Abstract Iris melanocytoma is a rare melanocytic nevus with distinctive clinical and pathologic features. Secondary glaucoma may develop rapidly and respond poorly to glaucoma medication in some cases. However, few data are available in the literature with respect to the appropriate treatment for refractory glaucoma associated with iris melanocytoma. Herein, we present a 28-year-old man with blurred vision and an elevated intraocular pressure (IOP) of 40 mmHg in his right eye while on multiple glaucoma medications. A dark brown lobulated iris mass with surrounding small pigmented lesions was noted between the 4 and 5:30 o'clock positions. Sector iridectomy was performed and pathologic examination revealed an iris melanocytoma. After surgery, antiglaucomatous medications still failed to control IOP. The patient then underwent diode laser transscleral cyclophotocoagulation (TSCP). At the last follow-up of 15 months, IOP had returned to normal without the need for medication. © 2008 by Lippincott Williams & Wilkins, Inc.